20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with l 663536 in 2 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (l 663536) | Trials (l 663536) | Recent Studies (post-2010) (l 663536) |
---|---|---|---|---|---|
640 | 13 | 233 | 485 | 4 | 138 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, CJ; Ma, YH; Tseng, CP; Yang, CM | 1 |
Chen, R; Cheng, O; Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Zhang, J | 1 |
2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and l 663536
Article | Year |
---|---|
20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cyclooxygenase 2; Hydroxyeicosatetraenoic Acids; Indoles; Luciferases; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; PPAR alpha; Promoter Regions, Genetic; Pyrimidines; Rats; RNA, Small Interfering; Transcription Factor AP-1 | 2011 |
Effects of PPARs/20-HETE on the renal impairment under diabetic conditions.
Topics: Amidines; Anilides; Animals; Cell Line; Cytochrome P-450 CYP4A; Diabetic Nephropathies; Down-Regulation; Epithelial Cells; Gene Expression Regulation; Glucose; Hydroxyeicosatetraenoic Acids; Indoles; Kidney Tubules; Male; Mice; PPAR alpha; PPAR gamma; PPAR-beta; Rats; Sulfones; Thiophenes | 2019 |